117 related articles for article (PubMed ID: 3501031)
1. Leukemia-associated inhibitory activity in acute leukemia developed from myelodysplastic syndrome.
Fukuoka T; Fujita S
Jpn J Med; 1987 Aug; 26(3):314-8. PubMed ID: 3501031
[TBL] [Abstract][Full Text] [Related]
2. Myelodysplastic syndrome (MDS)-associated inhibitory activity on haemopoietic progenitor cells.
Ohmori M; Ohmori S; Ueda Y; Tohyama K; Yoshida Y; Uchino H
Br J Haematol; 1990 Feb; 74(2):179-84. PubMed ID: 2180470
[TBL] [Abstract][Full Text] [Related]
3. Production, characteristics and mode of action of hemopoietic growth inhibitors in myeloid leukemias.
Olsson I; Olofsson T
Med Oncol Tumor Pharmacother; 1985; 2(1):1-6. PubMed ID: 3877222
[TBL] [Abstract][Full Text] [Related]
4. Persistence of inhibitory activity against normal bone-marrow cells during remission of acute leukemia.
Broxmeyer HE; Grossbard E; Jacobsen N; Moore MA
N Engl J Med; 1979 Aug; 301(7):346-51. PubMed ID: 313511
[TBL] [Abstract][Full Text] [Related]
5. Acidic isoferritins (leukemia-associated inhibitory activity) fail to inhibit blast proliferation in acute myelogenous leukemia.
Taetle R
Blood; 1981 Sep; 58(3):653-7. PubMed ID: 6973349
[TBL] [Abstract][Full Text] [Related]
6. Identification of leukemia-associated inhibitory activity as acidic isoferritins. A regulatory role for acidic isoferritins in the production of granulocytes and macrophages.
Broxmeyer HE; Bognacki J; Dorner MH; de Sousa M
J Exp Med; 1981 Jun; 153(6):1426-44. PubMed ID: 6972999
[TBL] [Abstract][Full Text] [Related]
7. Peripheral blood granulocyte-macrophage progenitors in patients with the myelodysplastic syndromes.
Tennant GB; Jacobs A; Bailey-Wood R
Exp Hematol; 1986 Dec; 14(11):1063-8. PubMed ID: 3780888
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of granulocyte-macrophage colony formation in chronic myelomonocytic leukemia: a comparative study with other myelodysplastic and myeloproliferative disorders.
Yuo A; Miyazono K; Urabe A; Takaku F
Jpn J Cancer Res; 1990 Aug; 81(8):820-6. PubMed ID: 2118895
[TBL] [Abstract][Full Text] [Related]
9. In vitro growth of myeloid and erythroid progenitor cells from myelodysplastic patients in response to recombinant human granulocyte-macrophage colony-stimulating factor.
Mayani H; Baines P; Bowen DT; Jacobs A
Leukemia; 1989 Jan; 3(1):29-32. PubMed ID: 2642575
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic values of in vitro culture growth patterns of marrow granulocyte-macrophage progenitors in patients with myelodysplastic syndrome.
Shih LY; Chiu WF; Lee CT
Leukemia; 1991 Dec; 5(12):1092-8. PubMed ID: 1774958
[TBL] [Abstract][Full Text] [Related]
11. MDS-macrophage derived inhibitory activity on myelopoiesis of MDS abnormal clones.
Ohmori S; Ohmori M; Yamagishi M; Okuma M
Br J Haematol; 1993 Mar; 83(3):388-91. PubMed ID: 8485044
[TBL] [Abstract][Full Text] [Related]
12. Myelodysplastic syndrome (MDS)-associated inhibitory activity on haematopoietic progenitor cells: contribution of monocyte-derived lipid containing macrophages (MDLM).
Ohmori M; Ueda Y; Masutani H; Hirama T; Anzai N; Yoshida Y; Okuma M
Br J Haematol; 1992 May; 81(1):67-72. PubMed ID: 1520627
[TBL] [Abstract][Full Text] [Related]
13. Induction of leukemia-associated inhibitory activity and bone marrow granulocyte-macrophage progenitor cell alterations during infection with Abelson virus.
Broxmeyer HE; Ralph P; Gilbertson S; Margolis VB
Cancer Res; 1980 Nov; 40(11):3928-33. PubMed ID: 6258770
[TBL] [Abstract][Full Text] [Related]
14. Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes.
Nagler A; Ginzton N; Negrin R; Bang D; Donlon T; Greenberg P
Leukemia; 1990 Mar; 4(3):193-202. PubMed ID: 1690318
[TBL] [Abstract][Full Text] [Related]
15. Leukemic cell-associated inhibitory activity against CFU-C of normal bone marrow.
Itoh K; Fujioka S; Yoshida S
Nihon Ketsueki Gakkai Zasshi; 1985 Feb; 48(1):47-54. PubMed ID: 3873776
[No Abstract] [Full Text] [Related]
16. Identification of leukemia cell-derived inhibitory activity (LIA) in conditioned media from human myeloid leukemic cell line ML-2.
Cukrová V; Hrkal Z; Koprivová H; Neuwirt J
Blut; 1986 Jan; 52(1):51-8. PubMed ID: 3484646
[TBL] [Abstract][Full Text] [Related]
17. [Determination of inhibitory activity derived from leukemic cells and its use in clinical practice].
Cukrová V; Neuwirtová R; Novák F; Cermák J
Vnitr Lek; 1987 Mar; 33(3):241-7. PubMed ID: 3499031
[No Abstract] [Full Text] [Related]
18. Thrombopoietin stimulates myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferation.
Ferrajoli A; Talpaz M; Kurzrock R; Harris D; Van Q; Estey EH; Estrov Z
Leuk Lymphoma; 1998 Jul; 30(3-4):279-92. PubMed ID: 9713960
[TBL] [Abstract][Full Text] [Related]
19. Ineffective hemopoiesis in the myelodysplastic syndromes (MDS) as studied by daily in situ observation of colony-cluster formation.
Ohmori M; Ohmori S; Ueda Y; Yoshida Y; Okuma M
Int J Cell Cloning; 1991 Sep; 9(5):521-30. PubMed ID: 1955740
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the production of leukemia associated inhibitor (LAI) and its interaction with granulocyte-macrophage colony-forming cells.
Olofsson T; Sallerfors B
Exp Hematol; 1987 Dec; 15(11):1163-7. PubMed ID: 3500070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
